Insiders · SGP

SGP insider transactions

SpyGlass Pharma Inc. (SGP) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for SGP

• 73d
  Director Ra Capital Management, L.P. converted options into 4,331,117 shares and bought $59,040,000 worth of shares (3,690,000 units at $16.00) (SEC Form 4)

  4 - SpyGlass Pharma, Inc. (0001778922) (Issuer)
• 73d
  Amendment: SEC Form 4 filed by Director Nielsen Kirk G.

  4/A - SpyGlass Pharma, Inc. (0001778922) (Issuer)
• 74d
  Large owner Florence Anthony A. Jr. converted options into 6,454,801 shares and bought $15,000,000 worth of shares (937,500 units at $16.00) (SEC Form 4)

  4 - SpyGlass Pharma, Inc. (0001778922) (Issuer)
• 74d
  Director Behbahani Ali converted options into 6,454,801 shares and bought $15,000,000 worth of shares (937,500 units at $16.00) (SEC Form 4)

  4 - SpyGlass Pharma, Inc. (0001778922) (Issuer)
• 74d
  Large owner Yang Rick converted options into 5,097,538 shares and bought $15,000,000 worth of shares (937,500 units at $16.00) (SEC Form 4)

  4 - SpyGlass Pharma, Inc. (0001778922) (Issuer)
• 74d
  Large owner Baskett Forest converted options into 6,454,801 shares and bought $15,000,000 worth of shares (937,500 units at $16.00) (SEC Form 4)

  4 - SpyGlass Pharma, Inc. (0001778922) (Issuer)
• 74d
  Large owner New Enterprise Associates 17, L.P. converted options into 5,097,538 shares and bought $15,000,000 worth of shares (937,500 units at $16.00) (SEC Form 4)

  4 - SpyGlass Pharma, Inc. (0001778922) (Issuer)
• 74d
  Large owner Makhzoumi Mohamad converted options into 6,454,801 shares and bought $15,000,000 worth of shares (937,500 units at $16.00) (SEC Form 4)

  4 - SpyGlass Pharma, Inc. (0001778922) (Issuer)
• 74d
  Large owner Sandell Scott D converted options into 6,454,801 shares and bought $15,000,000 worth of shares (937,500 units at $16.00) (SEC Form 4)

  4 - SpyGlass Pharma, Inc. (0001778922) (Issuer)
• 74d
  Large owner Mathers Edward T converted options into 5,097,538 shares and bought $15,000,000 worth of shares (937,500 units at $16.00) (SEC Form 4)

  4 - SpyGlass Pharma, Inc. (0001778922) (Issuer)
• 74d
  Large owner Walker Paul Edward converted options into 6,454,801 shares and bought $15,000,000 worth of shares (937,500 units at $16.00) (SEC Form 4)

  4 - SpyGlass Pharma, Inc. (0001778922) (Issuer)
• 74d
  Large owner Chang Carmen converted options into 6,454,801 shares and bought $15,000,000 worth of shares (937,500 units at $16.00) (SEC Form 4)

  4 - SpyGlass Pharma, Inc. (0001778922) (Issuer)
• 74d
  Director Pardo Geoffrey B converted options into 1,875,013 shares and bought $5,000,000 worth of shares (312,500 units at $16.00) (SEC Form 4)

  4 - SpyGlass Pharma, Inc. (0001778922) (Issuer)
• 74d
  Director Khan Bilal Arshad bought $2,160,000 worth of shares (135,000 units at $16.00), increasing direct ownership by 367% to 25,450 units (SEC Form 4)

  4 - SpyGlass Pharma, Inc. (0001778922) (Issuer)
• 74d
  Director Nielsen Kirk G. converted options into 3,145,619 shares and bought $2,640,000 worth of shares (165,000 units at $16.00) (SEC Form 4)

  4 - SpyGlass Pharma, Inc. (0001778922) (Issuer)
• 74d
  Large owner Vensana Capital I Gp, Llc converted options into 3,145,619 shares and bought $2,640,000 worth of shares (165,000 units at $16.00) (SEC Form 4)

  4 - SpyGlass Pharma, Inc. (0001778922) (Issuer)
• 76d
  SEC Form 4 filed by Director Ra Capital Management, L.P.

  4 - SpyGlass Pharma, Inc. (0001778922) (Issuer)
• 76d
  SEC Form 4 filed by Director Behbahani Ali

  4 - SpyGlass Pharma, Inc. (0001778922) (Issuer)
• 76d
  SEC Form 4 filed by Director Nielsen Kirk G.

  4 - SpyGlass Pharma, Inc. (0001778922) (Issuer)
• 76d
  SEC Form 4 filed by Director Scheiner Zachary

  4 - SpyGlass Pharma, Inc. (0001778922) (Issuer)
• 76d
  SEC Form 4 filed by Director Khan Bilal Arshad

  4 - SpyGlass Pharma, Inc. (0001778922) (Issuer)
• 76d
  SEC Form 4 filed by Director Dable Habib J

  4 - SpyGlass Pharma, Inc. (0001778922) (Issuer)
• 76d
  SEC Form 4 filed by Director Pardo Geoffrey B

  4 - SpyGlass Pharma, Inc. (0001778922) (Issuer)
• 76d
  SEC Form 4 filed by Director Dybbs Michael

  4 - SpyGlass Pharma, Inc. (0001778922) (Issuer)
• 76d
  SEC Form 4 filed by Director O'Farrell Elizabeth G.

  4 - SpyGlass Pharma, Inc. (0001778922) (Issuer)
• 76d
  SEC Form 4 filed by Chief Operating Officer Dennewill James Robert Jr.

  4 - SpyGlass Pharma, Inc. (0001778922) (Issuer)
• 76d
  SEC Form 4 filed by Chief R&D Officer Pujara Chetan Pratap

  4 - SpyGlass Pharma, Inc. (0001778922) (Issuer)
• 76d
  SEC Form 4 filed by Officer Kahook Malik Y.

  4 - SpyGlass Pharma, Inc. (0001778922) (Issuer)
• 76d
  SEC Form 4 filed by Chief Financial Officer Viret Jean-Frederic

  4 - SpyGlass Pharma, Inc. (0001778922) (Issuer)
• 76d
  SEC Form 4 filed by Chief Executive Officer Mooney Patrick H.

  4 - SpyGlass Pharma, Inc. (0001778922) (Issuer)